RESUMO
The review contains data on rates of permanent loss of working ability (disability) after coronary artery bypass grafting (CABG) in Russia and in European populations of patients with ischemic heart disease. According to domestic studies determination of disability status is not based on assessment of objective characteristics of functional reserve of cardiovascular system. Most patients after surgery retain disability status. CABG is not a rehabilitating factor but on the contrary results in increase of number of officially disabled people.
Assuntos
Ponte de Artéria Coronária , Doença da Artéria Coronariana/cirurgia , Avaliação da Deficiência , Idoso , Doença da Artéria Coronariana/psicologia , Humanos , Federação Russa , Resultado do TratamentoRESUMO
Aim of the study was to assess factors influencing decisions about persistent disability of patients after coronary bypass surgery (CBS). By method of continuous sampling (registry study) we examined 427 working age patients who had undergone CBS. Although surgical treatment was effective rehabilitating factor most patients after CBS at inspection in institutions of medical social expertise were unreasonably classified as having low degree of restoration of ability to work. Possible explanations of this were incomplete volume of conducted tests, lack of relation between presence of functional class of angina and real clinical picture of this syndrome, absence of objective criteria of the presence of myocardial ischemia and tolerance to physical exercise, ill-timed referral to medical social inspection.
Assuntos
Ponte de Artéria Coronária , Isquemia Miocárdica/cirurgia , Avaliação da Capacidade de Trabalho , Ponte de Artéria Coronária/efeitos adversos , Ponte de Artéria Coronária/métodos , Tolerância ao Exercício , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Isquemia Miocárdica/diagnóstico , Isquemia Miocárdica/fisiopatologia , Avaliação de Resultados em Cuidados de Saúde , Gravidade do Paciente , Período Perioperatório , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/fisiopatologia , Complicações Pós-Operatórias/reabilitaçãoRESUMO
In this study quadropril (Spirapril, Pliva) was given for 2 months to patients with arterial hypertension combined with chronic obstructive pulmonary disease. The results show that quadropril (6 mg/day) is highly effective as monotherapy in patients with mild and moderate hypertensive disease. Its effects appear as significant lowering of mean 24 hour systolic and diastolic blood pressure (BP), lowering of diurnal and nocturnal BP. Therapy with quadropril for 8 weeks did not impair parameters of external respiration, produced no negative action on lipid and carbohydrate metabolism, was well tolerated, and caused no considerable side effects.
